The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study. (Record no. 29880172)

MARC details
000 -LEADER
fixed length control field 02560 a2200733 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518050412.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202006s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1879-0852
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ejca.2019.06.001
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Di Cosimo, Serena
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200608
245 00 - TITLE STATEMENT
Title The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of cancer (Oxford, England : 1990)
Date of publication, distribution, etc. 09 2019
300 ## - PHYSICAL DESCRIPTION
Extent 1-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Immunological
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers, Tumor
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemotherapy, Adjuvant
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Decision-Making
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clinical Trials, Phase III as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gene Expression Profiling
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lapatinib
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multicenter Studies as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoadjuvant Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Patient Selection
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Precision Medicine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Predictive Value of Tests
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptor, ErbB-2
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Transcriptome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Trastuzumab
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Triulzi, Tiziana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pizzamiglio, Sara
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name De Cecco, Loris
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de Azambuja, Evandro
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fumagalli, Debora
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Putzai, Lajos
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Harbeck, Nadia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Izquierdo, Miguel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Peña, Lorena de la
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Daidone, Maria Grazia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huober, Jens
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gori, Stefania
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cinieri, Saverio
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Torri, Valter
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Baselga, Jose
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Piccart, Martine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de Braud, Filippo G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Apolone, Giovanni
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Verderio, Paolo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tagliabue, Elda
773 0# - HOST ITEM ENTRY
Title European journal of cancer (Oxford, England : 1990)
Related parts vol. 118
-- p. 1-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ejca.2019.06.001">https://doi.org/10.1016/j.ejca.2019.06.001</a>
Public note Available from publisher's website

No items available.